These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21320256)

  • 1. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention.
    Berk M; Brnabic A; Dodd S; Kelin K; Tohen M; Malhi GS; Berk L; Conus P; McGorry PD
    Bipolar Disord; 2011 Feb; 13(1):87-98. PubMed ID: 21320256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
    Ketter TA; Houston JP; Adams DH; Risser RC; Meyers AL; Williamson DJ; Tohen M
    J Clin Psychiatry; 2006 Jan; 67(1):95-101. PubMed ID: 16426094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
    Tohen M; Ketter TA; Zarate CA; Suppes T; Frye M; Altshuler L; Zajecka J; Schuh LM; Risser RC; Brown E; Baker RW
    Am J Psychiatry; 2003 Jul; 160(7):1263-71. PubMed ID: 12832240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
    Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variables as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study.
    Tohen M; Wang WV; Leboyer M; Jen KY
    J Clin Psychiatry; 2012 Jul; 73(7):e913-7. PubMed ID: 22901362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
    J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Staging of bipolar affective illness].
    Ferensztajn E; Rybakowski J
    Psychiatr Pol; 2012; 46(4):613-26. PubMed ID: 23214163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder.
    Tohen M; Sutton VK; Calabrese JR; Sachs GS; Bowden CL
    J Affect Disord; 2009 Jul; 116(1-2):43-50. PubMed ID: 19054570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
    Tohen M; Calabrese JR; Sachs GS; Banov MD; Detke HC; Risser R; Baker RW; Chou JC; Bowden CL
    Am J Psychiatry; 2006 Feb; 163(2):247-56. PubMed ID: 16449478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.
    Tohen M; Zarate CA; Hennen J; Khalsa HM; Strakowski SM; Gebre-Medhin P; Salvatore P; Baldessarini RJ
    Am J Psychiatry; 2003 Dec; 160(12):2099-107. PubMed ID: 14638578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.
    Tohen M; Goldberg JF; Gonzalez-Pinto Arrillaga AM; Azorin JM; Vieta E; Hardy-Bayle MC; Lawson WB; Emsley RA; Zhang F; Baker RW; Risser RC; Namjoshi MA; Evans AR; Breier A
    Arch Gen Psychiatry; 2003 Dec; 60(12):1218-26. PubMed ID: 14662554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of past direct-personal traumatic events on 12-month outcome in first episode psychotic mania: trauma and early psychotic mania.
    Daglas R; Conus P; Cotton SM; Macneil CA; Hasty MK; Kader L; Berk M; Hallam KT
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1017-24. PubMed ID: 25122448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.
    Berk M; Ng F; Wang WV; Tohen M; Lubman DI; Vieta E; Dodd S
    J Affect Disord; 2008 Sep; 110(1-2):126-34. PubMed ID: 18280579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of the efficacy of double-blind, placebo-controlled one-week olanzapine stabilization therapy in heterogeneous symptomatic bipolar disorder patients.
    Srivastava S; Wang PW; Hill SJ; Childers ME; Keller KL; Ketter TA
    J Psychiatr Res; 2012 Jul; 46(7):920-6. PubMed ID: 22579071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine versus placebo in acute mania: treatment responses in subgroups.
    Baldessarini RJ; Hennen J; Wilson M; Calabrese J; Chengappa R; Keck PE; McElroy SL; Sachs G; Vieta E; Welge JA; Yatham LN; Zarate CA; Baker RW; Tohen M
    J Clin Psychopharmacol; 2003 Aug; 23(4):370-6. PubMed ID: 12920413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.